title: Analysis of opioid-seeking reinstatement in the rat.
abstract: The inability to maintain drug abstinence is often referred to as relapse and consists of a process by which an abstaining individual slips back into old behavioral patterns and substance use. Animal models of relapse have been developed and validated over the last decades, and significantly contributed to shed light on the neurobiological mechanisms underlying vulnerability to relapse. The most common procedure to study drug-seeking and relapse-like behavior in animals is the "reinstatement model." Originally elaborated by Pavlov and Skinner, the concepts of reinforced operant responding and conditioned behavior were applied to addiction research not before 1971 (Stretch et al., Can J Physiol Pharmacol 49:581-589, 1971), and the first report of a reinstatement animal model as it is now used worldwide was published only 10 years later (De Wit and Stewart, Psychopharmacology 75:134-143, 1981). According to the proposed model, opioids are typically self-administered intravenously, as humans do, and although rodents are most often employed in these studies, this model has been used with a variety of species including nonhuman primates, dogs, cats, and pigeons. A variety of operant responses are available, depending on the species studied. For example, a lever press or a nose poke response typically is used for rodents, whereas a panel press response typically is used for nonhuman primates. Here, we describe a simple and easily reproducible protocol of heroin-seeking reinstatement in rats, which proved useful to study the neurobiological mechanisms underlying relapse to heroin and vulnerability factors enhancing the resumption of heroin-seeking behavior.
authors.affiliation: CNR National Research Council of Italy, Institute of Neuroscience-Cagliari, Cagliari, Italy.
authors.forename: Liana
authors.initials: L
authors.lastname: Fattore
authors.forename: Paola
authors.initials: P
authors.lastname: Fadda
authors.forename: Mary Tresa
authors.initials: MT
authors.lastname: Zanda
authors.forename: Walter
authors.initials: W
authors.lastname: Fratta
mesh_terms: D000701:Analgesics, Opioid / Q000633:toxicity; D000818:Animals; D016739:Behavior, Addictive; D003042:Cocaine / Q000633:toxicity; D003216:Conditioning, Operant; D004195:Disease Models, Animal; D003932:Heroin / Q000633:toxicity; D006801:Humans; D009293:Opioid-Related Disorders / Q000378:metabolism* / Q000503:physiopathology; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000503:physiopathology*
chemical_list: D000701:Analgesics, Opioid; D011957:Receptors, Opioid; D003932:Heroin; D003042:Cocaine